I've been reading about Keytruda from Merck. It's not been successful in 3 recent clinical trials for PCa but I may be invited to a new one that is assessing Keytruda as a neoadjuvant.
clinicaltrials.gov/study/NC...
I've found a few stories here about Keytruda and I see some scary side effects. But I'm willing to balance that anxiety against the hope that being involved in research like this is key for future survivors of PCa.
This is just a placeholder for now and I'll add more later if I'm enrolled.
10/1 updated: Oops, I just realized this is not Keytruda at all. But enoblituzumab. Sorry if I misled anyone.